Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ELDN Eledon Pharmaceuticals Inc

3,25

0,45 (16,07%)

18 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Eledon Pharmaceuticals (NASDAQ:ELDN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Eledon Pharmaceuticals Charts.

Eledon Pharmaceuticals (NASDAQ:ELDN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Eledon Pharmaceuticals Charts.

News Eledon Pharmaceuticals Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
Donnerstag 9 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
Montag 25 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Eledon Pharmaceuticals Inc News-Artikel

Resource Centrix

Hsbc Msci South Africa C...

BNP Paribas Issuance

Central Del Latte Di Tor...

Treasury Metals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen